These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11367373)

  • 21. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C; Romeu J; Sirera G; Andreu D; Conejero M; Ruiz S; Jou A; Bonjoch A; Ruiz L; Arnó A; Clotet B
    J Infect Dis; 1998 Apr; 177(4):1080-3. PubMed ID: 9534987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
    Mitchell SM; Membrey WL; Youle MS; Obi A; Worrell S; Gazzard BG
    Br J Ophthalmol; 1999 Jun; 83(6):652-5. PubMed ID: 10340970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
    Wohl DA; Kendall MA; Owens S; Holland G; Nokta M; Spector SA; Schrier R; Fiscus S; Davis M; Jacobson MA; Currier JS; Squires K; Alston-Smith B; Andersen J; Freeman WR; Higgins M; Torriani FJ;
    HIV Clin Trials; 2005; 6(3):136-46. PubMed ID: 16192248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy.
    Song MK; Schrier RD; Smith IL; Plummer DJ; Freeman WR
    Retina; 2002 Jun; 22(3):262-7. PubMed ID: 12055457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.
    Verbraak FD; Boom R; Wertheim-van Dillen PM; van den Horn GJ; Kijlstra A; de Smet MD
    Br J Ophthalmol; 1999 Oct; 83(10):1186-9. PubMed ID: 10502584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of CMV retinitis in the era of highly active antiretroviral therapy.
    Jouan M; Katlama C
    Int J Antimicrob Agents; 1999 Sep; 13(1):1-7. PubMed ID: 10563398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing patterns of HIV related ocular disease.
    Rauz S; Murray PI
    Sex Transm Infect; 1999 Feb; 75(1):18-20. PubMed ID: 10448336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus retinitis after initiation of antiretroviral therapy.
    Ahmadinejad Z; Ghetmiri Z; Rasoolinejad M
    Acta Med Iran; 2013; 51(10):730-2. PubMed ID: 24338150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Course of cytomegalovirus retinitis in HIV positive patients treated with triple antiretroviral therapy].
    Doan S; Badelon I; Chaine G
    J Fr Ophtalmol; 1998 Jan; 21(1):34-41. PubMed ID: 9834898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of highly active antiretroviral therapy on cytomegalovirus antigenaemia in AIDS patients.
    Borges LH; Villas Boas LS; Warren-Santoro SH; Estevam MP; Uip DE; Savalli C; Curi M; Pannuti CS
    Int J STD AIDS; 2001 Apr; 12(4):234-8. PubMed ID: 11319974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I; Ries E; Krepler K; Derbolav A; Rieger A; Armbruster C; Wedrich A
    Acta Ophthalmol Scand; 1999 Aug; 77(4):471-3. PubMed ID: 10463426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.
    Holbrook JT; Colvin R; van Natta ML; Thorne JE; Bardsley M; Jabs DA;
    Am J Ophthalmol; 2011 Oct; 152(4):628-637.e1. PubMed ID: 21742304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suspension of anticytomegalovirus maintenance therapy following immune recovery due to highly active antiretroviral therapy.
    Curi AL; Muralha A; Muralha L; Pavesio C
    Br J Ophthalmol; 2001 Apr; 85(4):471-3. PubMed ID: 11264139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CMV retinitis in the era of HAART.
    Cassoux N; Bodaghi B; Katlama C; LeHoang P
    Ocul Immunol Inflamm; 1999 Dec; 7(3-4):231-5. PubMed ID: 10611732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.
    Karavellas MP; Plummer DJ; Macdonald JC; Torriani FJ; Shufelt CL; Azen SP; Freeman WR
    J Infect Dis; 1999 Mar; 179(3):697-700. PubMed ID: 9952380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L
    West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stopping CMV prophylaxis with HAART.
    TreatmentUpdate; 1998 Sep; 10(7):4-6. PubMed ID: 11365782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.
    Kempen JH; Jabs DA; Dunn JP; West SK; Tonascia J
    Arch Ophthalmol; 2001 Jan; 119(1):33-40. PubMed ID: 11146724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.